Publications by authors named "Thierry Velu"

Claim this Profile
S
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival.
Cornelis J M Melief, Marij J P Welters, Ignace Vergote, Judith R Kroep, Gemma G Kenter, Thierry Velu

Sci Transl Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence.
Stefaan Mulier, Jean-Pierre Claes, Vincent Dierieck, Jean-Olivier Amiel, Jean-Philippe Pahaut, Thierry Velu

Curr Pharm Des· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugeniu Banu, Thierry Velu

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.
Gregory Driessens, Lise Nuttin, Alain Gras, Julie Maetens, Stephane Mievis, Thierry Velu

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities.
Laurent Castera, Anne Sophie Hatzfeld-Charbonnier, Caroline Ballot, Florence Charbonnel, Edith Dhuiege, Thierry Velu

J Cell Mol Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
Gregory Driessens, Paul Hoffmann, Michael Pouwels, Alexandre Zlotta, Claude Schulman, Thierry Velu

J Immunother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Gregory Driessens, Laurence Gordower, Lise Nuttin, Patrick Stordeur, Didier Blocklet, Thierry Velu

Cancer Immunol Immunother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.
Rodryg Ramlau, Elisabeth Quoix, Janusz Rolski, Miklos Pless, Herve Lena, Thierry Velu

J Thorac Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma.
Reinhard Dummer, Christoph Rochlitz, Thierry Velu, Bruce Acres, Jean-Marc Limacher

Mol Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines.
Anne Sophie Hatzfeld-Charbonnier, Audrey Lasek, Laurent Castera, Philippe Gosset, Thierry Velu

J Leukoc Biol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Margarita Salcedo, Nadège Bercovici, Rachel Taylor, Pierre Vereecken, Séverine Massicard, Thierry Velu

Cancer Immunol Immunother· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of cell hybrids via a fusogenic cell line.
Siew Chiat Cheong, Isabelle Blangenois, Jean-Denis Franssen, Charlotte Servais, Vy Phan, Thierry Velu

J Gene Med· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxic-response elements in the oncolytic parvovirus Minute virus of mice do not allow for increased vector production at low oxygen concentration.
Charlotte Servais, Perrine Caillet-Fauquet, Marie-Louise Draps, Thierry Velu, Yvan de Launoit

J Gen Virol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
Myrto Trakatelli, Michel Toungouz, Didier Blocklet, Ygierne Dodoo, Laurence Gordower, Thierry Velu

Cancer Immunol Immunother· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.
Ulrich Keilholz, Cornelis J A Punt, Martin Gore, Wim Kruit, Poulam Patel, Thierry Velu

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes.
Myrto Trakatelli, Michel Toungouz, Micheline Lambermont, Michel Heenen, Thierry Velu

Cancer Gene Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
Karim El Bakkouri, Charlotte Servais, Nathalie Clément, Siew Chiat Cheong, Jean-Denis Franssen, Thierry Velu

J Gene Med· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.
Catherine Germeau, Wenbin Ma, Francesca Schiavetti, Christophe Lurquin, Emmanuelle Henry, Thierry Velu

J Exp Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor.
Gregory Driessens, Malika Hamdane, Vincent Cool, Thierry Velu, Catherine Bruyns

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity.
Eric Mallard, Frédérique Vernel-Pauillac, Thierry Velu, Frédéric Lehmann, Jean-Pierre Abastado

J Immunol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
Annick Brandenburger, Thierry Velu

J Gene Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minocycline-induced activation of tetracycline-responsive promoter.
Abdelwahed Chtarto, Liliane Tenenbaum, Thierry Velu, Jacques Brotchi, Marc Levivier

Neurosci Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of in vivo chemotherapy-induced DNA damage in a p53-mutated rat tumor by micronuclei assay.
Gregory Driessens, Laura Harsan, Patrick Browaeys, Xenofon Giannakopoulos, Thierry Velu

Ann N Y Acad Sci· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.
Vaios Karanikas, Christophe Lurquin, Didier Colau, Nicolas van Baren, Charles De Smet, Thierry Velu

J Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy.
Ernesto Bali, François Willermain, Laure Caspers-Velu, Christine Dubois, Marie-Françoise Dehou, Thierry Velu

Int J Mol Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis